Reversal of Delirium Induced by Tricyclic Antidepressant Drugs with Physostigmine
- 1 November 1974
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 131 (11) , 1275-1277
- https://doi.org/10.1176/ajp.131.11.1275
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Reversal of Antiparkinsonian Drug Toxicity by Physostigmine: A Controlled StudyAmerican Journal of Psychiatry, 1973
- A CHOLINERGIC-ADRENERGIC HYPOTHESIS OF MANIA AND DEPRESSIONThe Lancet, 1972
- Confusional Episodes and Antidepressant MedicationAmerican Journal of Psychiatry, 1971
- Cardiac Complications of Tricyclic Antidepressant TherapyAnnals of Internal Medicine, 1971
- The Reversal of Anticholinergic Drug-Induced Delirium and Coma with PhysostigmineAmerican Journal of Psychiatry, 1971
- Physostigmine Therapy in Acute Tricyclic Antidepressant PoisoningClinical Toxicology, 1971
- AMITRIPTYLINE AND CARDIAC DISEASE: Risk of Sudden Death Identified by Monitoring SystemThe Lancet, 1970
- TREATMENT OF SCOPOLAMINE-INDUCED DELIRIUMThe Lancet, 1970
- Reversal of Central Anticholinergic Syndrome in Man by PhysostigmineJAMA, 1968
- Electrocardiographic Changes in Amitriptyline PoisoningBMJ, 1968